MetaCap

ResMed Statistics

NYSE: RMDHealth CareMedical/Dental InstrumentsUSD

235.63-1.25 (-0.53%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ResMed by the numbers

ResMed has a market capitalization of $33.14 billion based on 140.66M shares outstanding. Its trailing P/E ratio is 21.5, below the 6-company peer median of 62.1, and its forward P/E is 17.8. The stock trades 0.8% above its 50-day average and 5.5% above its 200-day average.

Average daily trading volume is 1.30M shares, or about $307.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RMD valuation vs. peer median

RMD compared with the median of 8 peer companies
MetricRMDPeer medianDifference
Market cap$33.14B$14.20B+133%
P/E (TTM)21.562.1-65%
Forward P/E17.824.6-28%
Avg. volume1.30M1.40M-7%

Peer median across 8 companies: DXCM, WST, MDLN, SOLV, GKOS, BAX, PEN, PODD.

Valuation

Market cap
$33.14B
Price / sales (latest FY)
5.86
EPS (TTM)
$10.98

Price and trading

Previous close
236.88
Open
237.18
Day range
234.70 – 242.43
52-week range
180.27 – 277.67
52-week change
-6.03%
Beta
—
Volume
1.37M

Dividends and events

Annual dividend
$2.46
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
33.14B
Pe
21.46
Forward Pe
17.82
Eps
10.98
Dividend Yield
112.00%
Dividend Rate
2.46
Week52 High
277.67
Week52 Low
180.27
Avg Volume
1.30M
Shares Outstanding
140.66M
Ma50
233.84
Ma200
223.35
Earnings Date
Oct 29, 2026
Pct From52w High
-15.14%
Pct From52w Low
30.71%

Related